Recently, researchers have found that bone strength with drugs, cancer of the bone density in patients with breast. Research shows that increasing number of drugs can really help boost bone cancer in the treatment of breast cancer. It may reduce the spread of cancer and also the need to control chemotherapy.
The side effects of chemotherapy that causes the greater loss of bone mass. Cancer cells that are released from a Breast cancer tends to be the first step in the bone marrow and then spread to other parts of the body. Currently, there are bone strengthening drugs such as Zometa, which have low bone density in human beings. The essential component of the drug zoledronic acid. This acid reduces bone loss, which may be caused by chemotherapy and slows down the activity of tumor cells to bone marrow corner home.
In> Cancer is the main problem is that the cells spread from one region to another, and if they are controlled, then the disease can be controlled. The effectiveness of the chemotherapy drug was tested on 120 women have been i. These women were given 4 mg of zoledronic acid once in 3 weeks for about a year. After 3 months of treatment, there was a significant improvement in women, and found that there are fewer cancer cells in the body. Normally, the bonebone marrow cells for the presence of cancer. If the number of cancer cells is lower, then it can be controlled has confirmed that his cancer is. The results were also women who have just been compared to chemotherapy, and have the same progress.
In addition, research participants who were after mass drug administration to strengthen the bone by a low bone density at the beginning of the normal process of bone-ended one yearTreatment.
No comments:
Post a Comment